advertisement
Yao K 14
Showing records 1 to 14 | Display all abstracts from Yao K105049 Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Yao K
Polymers 2022; 14:
104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
Sun X; Liu Q
BMC Ophthalmology 2022; 22: 332
105049 Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Liang X; Zhang G
Polymers 2022; 14:
104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
Tang X
BMC Ophthalmology 2022; 22: 332
105049 Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Rong Y
Polymers 2022; 14:
104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
Yao K; Li Y
BMC Ophthalmology 2022; 22: 332
105049 Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Zhang Q; Liao Q
Polymers 2022; 14:
104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
Yang J
BMC Ophthalmology 2022; 22: 332
105049 Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Zhang H
Polymers 2022; 14:
104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
Zhang M
BMC Ophthalmology 2022; 22: 332
105049 Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Xi K
Polymers 2022; 14:
104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
Yuan H
BMC Ophthalmology 2022; 22: 332
105049 Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Wang J
Polymers 2022; 14:
104851 Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China
Zheng Y; Li W; Peng H
BMC Ophthalmology 2022; 22: 332
